SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
INBX

Inhibrx Biosciences, Inc. (NASDAQ:INBX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
87.95-5.43 (-5.81%)
 
Market cap
$1.29B
Insider Score
Analyst consensus
Listed since
May 29, 2024
Insider Score
/ 100
INBX Insider Score

Inhibrx Biosciences, Inc. has a live Insider Score.

Scored on 20 qualifying trades from 3 insiders in the last 90 days.

Unlock the score

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

INBX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New INBX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to INBX from public contracts

Source: USAspending.gov

Recently reported changes in INBX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing INBX, reported under the STOCK Act.

PoliticianChamberActionAmountDate
No congressional trades recorded for INBX.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.